Black Rock Inc. Gritstone Bio, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Gritstone Bio, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 871,995 shares of GRTS stock, worth $26,159. This represents 0.0% of its overall portfolio holdings.

Number of Shares

871,995

Previous 5,789,668 84.94%

Holding current value

$26,159

Previous $14.9 Million 96.37%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$0.62 - $2.35 $3.05 Million - $11.6 Million	-4,917,673 Reduced 84.94%	871,995 $540,000
Q1 2024 May 10, 2024	SELL	$1.96 - $2.9 $154,222 - $228,186	-78,685 Reduced 1.34%	5,789,668 $14.9 Million
Q4 2023 Feb 13, 2024	SELL	$1.28 - $2.85 $281,210 - $626,133	-219,696 Reduced 3.61%	5,868,353 $12 Million
Q3 2023 Nov 13, 2023	SELL	$1.19 - $2.26 $149,205 - $283,365	-125,383 Reduced 2.02%	6,088,049 $10.5 Million
Q2 2023 Aug 11, 2023	BUY	$1.66 - $3.03 $7.11 Million - $13 Million	4,280,777 Added 221.5%	6,213,432 $12.1 Million
Q1 2023 May 12, 2023	SELL	$2.13 - $3.74 $46,602 - $81,827	-21,879 Reduced 1.12%	1,932,655 $5.37 Million
Q4 2022 Feb 13, 2023	BUY	$2.17 - $3.92 $62,022 - $112,041	28,582 Added 1.48%	1,954,534 $6.74 Million
Q3 2022 Nov 14, 2022	BUY	$2.46 - $4.75 $29,719 - $57,384	12,081 Added 0.63%	1,925,952 $4.95 Million
Q2 2022 Aug 12, 2022	SELL	$1.77 - $4.34 $3.5 Million - $8.59 Million	-1,979,522 Reduced 50.84%	1,913,871 $4.63 Million
Q1 2022 May 12, 2022	BUY	$4.03 - $12.19 $410,898 - $1.24 Million	101,960 Added 2.69%	3,893,393 $16 Million
Q4 2021 Feb 10, 2022	BUY	$8.76 - $13.71 $5.41 Million - $8.46 Million	617,115 Added 19.44%	3,791,433 $48.8 Million
Q3 2021 Nov 09, 2021	BUY	$6.41 - $13.54 $2.05 Million - $4.33 Million	319,450 Added 11.19%	3,174,318 $34.3 Million
Q2 2021 Aug 11, 2021	BUY	$8.13 - $10.2 $23.2 Million - $29.1 Million	2,854,868 New	2,854,868 $26.1 Million

Others Institutions Holding GRTS

# of Institutions

Shares Held

35.4M

Call Options Held

395K

Put Options Held

132K

View Full List

About Gritstone bio, Inc.

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $2.19M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

More about GRTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account